cola lipid c efficacy against albicans Brasil The monoclonal antibody Ca37, developed
The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo Scientific Reports Overcoming Candida albicans biofilm drug resistance via azole sophorolipid synergy Scientific Reports Full article: Synthesis and evaluation of Calenduloside E against drug resistant Candida albicans Nanostructured Lipid Carrier Based on Melaleuca Alternifolia and Bacuri Butter Associated with the Subdose of Amphotericin B: Cytotoxic and Antimicrobial Activity BioNanoScience Springer Nature Link Targeting Azole Resistant Candida albicans: Tetrapeptide Tuftsin Modified Liposomal Vaccine Induces Superior Immune Protection
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




